227 related articles for article (PubMed ID: 26767610)
1. Microvascular ischemia in hypertrophic cardiomyopathy: new insights from high-resolution combined quantification of perfusion and late gadolinium enhancement.
Villa AD; Sammut E; Zarinabad N; Carr-White G; Lee J; Bettencourt N; Razavi R; Nagel E; Chiribiri A
J Cardiovasc Magn Reson; 2016 Jan; 18():4. PubMed ID: 26767610
[TBL] [Abstract][Full Text] [Related]
2. Coronary microvascular ischemia in hypertrophic cardiomyopathy - a pixel-wise quantitative cardiovascular magnetic resonance perfusion study.
Ismail TF; Hsu LY; Greve AM; Gonçalves C; Jabbour A; Gulati A; Hewins B; Mistry N; Wage R; Roughton M; Ferreira PF; Gatehouse P; Firmin D; O'Hanlon R; Pennell DJ; Prasad SK; Arai AE
J Cardiovasc Magn Reson; 2014 Aug; 16(1):49. PubMed ID: 25160568
[TBL] [Abstract][Full Text] [Related]
3. 3.0 T magnetic resonance myocardial perfusion imaging for semi-quantitative evaluation of coronary microvascular dysfunction in hypertrophic cardiomyopathy.
Yin L; Xu HY; Zheng SS; Zhu Y; Xiao JX; Zhou W; Yu SS; Gong LG
Int J Cardiovasc Imaging; 2017 Dec; 33(12):1949-1959. PubMed ID: 28612277
[TBL] [Abstract][Full Text] [Related]
4. Inline perfusion mapping provides insights into the disease mechanism in hypertrophic cardiomyopathy.
Camaioni C; Knott KD; Augusto JB; Seraphim A; Rosmini S; Ricci F; Boubertakh R; Xue H; Hughes R; Captur G; Lopes LR; Brown LAE; Manisty C; Petersen SE; Plein S; Kellman P; Mohiddin SA; Moon JC
Heart; 2020 Jun; 106(11):824-829. PubMed ID: 31822572
[TBL] [Abstract][Full Text] [Related]
5. Myocardial perfusion reserve quantified by cardiac magnetic resonance imaging is associated with late gadolinium enhancement in hypertrophic cardiomyopathy.
Tezuka D; Kosuge H; Terashima M; Koyama N; Kishida T; Tada Y; Suzuki JI; Sasano T; Ashikaga T; Hirao K; Isobe M
Heart Vessels; 2018 May; 33(5):513-520. PubMed ID: 29168014
[TBL] [Abstract][Full Text] [Related]
6. Cardiovascular magnetic resonance predictors of heart failure in hypertrophic cardiomyopathy: the role of myocardial replacement fibrosis and the microcirculation.
Raphael CE; Mitchell F; Kanaganayagam GS; Liew AC; Di Pietro E; Vieira MS; Kanapeckaite L; Newsome S; Gregson J; Owen R; Hsu LY; Vassiliou V; Cooper R; Mrcp AA; Ismail TF; Wong B; Sun K; Gatehouse P; Firmin D; Cook S; Frenneaux M; Arai A; O'Hanlon R; Pennell DJ; Prasad SK
J Cardiovasc Magn Reson; 2021 Mar; 23(1):26. PubMed ID: 33685501
[TBL] [Abstract][Full Text] [Related]
7. Regional Stress-Induced Ischemia in Non-fibrotic Hypertrophied Myocardium in Young HCM Patients.
Jablonowski R; Fernlund E; Aletras AH; Engblom H; Heiberg E; Liuba P; Arheden H; Carlsson M
Pediatr Cardiol; 2015 Dec; 36(8):1662-9. PubMed ID: 26066352
[TBL] [Abstract][Full Text] [Related]
8. Influence of phase correction of late gadolinium enhancement images on scar signal quantification in patients with ischemic and non-ischemic cardiomyopathy.
Stirrat J; Joncas SX; Salerno M; Drangova M; White J
J Cardiovasc Magn Reson; 2015 Aug; 17(1):66. PubMed ID: 26248535
[TBL] [Abstract][Full Text] [Related]
9. Myocardial fibrosis in hypertrophic cardiomyopathy: accurate reflection of histopathological findings by CMR.
Moravsky G; Ofek E; Rakowski H; Butany J; Williams L; Ralph-Edwards A; Wintersperger BJ; Crean A
JACC Cardiovasc Imaging; 2013 May; 6(5):587-96. PubMed ID: 23582356
[TBL] [Abstract][Full Text] [Related]
10. CAD detection in patients with intermediate-high pre-test probability: low-dose CT delayed enhancement detects ischemic myocardial scar with moderate accuracy but does not improve performance of a stress-rest CT perfusion protocol.
Bettencourt N; Ferreira ND; Leite D; Carvalho M; Ferreira WDS; Schuster A; Chiribiri A; Leite-Moreira A; Silva-Cardoso J; Nagel E; Gama V
JACC Cardiovasc Imaging; 2013 Oct; 6(10):1062-1071. PubMed ID: 24011773
[TBL] [Abstract][Full Text] [Related]
11. Stress hypoperfusion and tissue injury in hypertrophic cardiomyopathy: spatial characterization using high-resolution 3-tesla magnetic resonance imaging.
Tyan CC; Armstrong S; Scholl D; Stirrat J; Blackwood K; El-Sherif O; Thompson T; Wisenberg G; Prato FS; So A; Lee TY; Drangova M; White JA
Circ Cardiovasc Imaging; 2013 Mar; 6(2):229-38. PubMed ID: 23413422
[TBL] [Abstract][Full Text] [Related]
12. Prevalence and clinical significance of cardiovascular magnetic resonance adenosine stress-induced myocardial perfusion defect in hypertrophic cardiomyopathy.
Kim EK; Lee SC; Chang SA; Jang SY; Kim SM; Park SJ; Choi JO; Park SW; Jeon ES; Choe YH
J Cardiovasc Magn Reson; 2020 May; 22(1):30. PubMed ID: 32366254
[TBL] [Abstract][Full Text] [Related]
13. Focal ischemic myocardial fibrosis assessed by late gadolinium enhancement cardiovascular magnetic resonance in patients with hypertrophic cardiomyopathy.
Zhi Y; Gui FD; Xue M; Long YT; Miao W; Yi Y; Gao LC; Bing F; Pan SY
BMC Cardiovasc Disord; 2024 Apr; 24(1):203. PubMed ID: 38594610
[TBL] [Abstract][Full Text] [Related]
14. Evidence for microvascular dysfunction in hypertrophic cardiomyopathy: new insights from multiparametric magnetic resonance imaging.
Petersen SE; Jerosch-Herold M; Hudsmith LE; Robson MD; Francis JM; Doll HA; Selvanayagam JB; Neubauer S; Watkins H
Circulation; 2007 May; 115(18):2418-25. PubMed ID: 17452610
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of techniques for the quantification of myocardial scar of differing etiology using cardiac magnetic resonance.
Flett AS; Hasleton J; Cook C; Hausenloy D; Quarta G; Ariti C; Muthurangu V; Moon JC
JACC Cardiovasc Imaging; 2011 Feb; 4(2):150-6. PubMed ID: 21329899
[TBL] [Abstract][Full Text] [Related]
16. Patterns of CMR measured longitudinal strain and its association with late gadolinium enhancement in patients with cardiac amyloidosis and its mimics.
Williams LK; Forero JF; Popovic ZB; Phelan D; Delgado D; Rakowski H; Wintersperger BJ; Thavendiranathan P
J Cardiovasc Magn Reson; 2017 Aug; 19(1):61. PubMed ID: 28784140
[TBL] [Abstract][Full Text] [Related]
17. "Myocardial transit-time" (MyoTT): a novel and easy-to-perform CMR parameter to assess microvascular disease.
Chatzantonis G; Bietenbeck M; Florian A; Meier C; Korthals D; Reinecke H; Yilmaz A
Clin Res Cardiol; 2020 Apr; 109(4):488-497. PubMed ID: 31321491
[TBL] [Abstract][Full Text] [Related]
18. Left ventricular geometric remodeling in relation to non-ischemic scar pattern on cardiac magnetic resonance imaging.
Kim J; Kochav JD; Gurevich S; Afroz A; Petashnick M; Volo S; Diaz B; Okin PM; Horn E; Devereux RB; Weinsaft JW
Int J Cardiovasc Imaging; 2014 Dec; 30(8):1559-67. PubMed ID: 25008088
[TBL] [Abstract][Full Text] [Related]
19. The current and emerging role of cardiovascular magnetic resonance imaging in hypertrophic cardiomyopathy.
Maron MS
J Cardiovasc Transl Res; 2009 Dec; 2(4):415-25. PubMed ID: 20560000
[TBL] [Abstract][Full Text] [Related]
20. Examining the impact of inducible ischemia on myocardial fibrosis and exercise capacity in hypertrophic cardiomyopathy.
Malahfji M; Senapati A; Debs D; Angulo C; Zhan Y; Nagueh SF; Shah DJ
Sci Rep; 2020 Sep; 10(1):15977. PubMed ID: 32994462
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
